OCT 06, 2015 8:04 AM PDT

Curing Hepatitis C and the Potential for Vaccines

WRITTEN BY: Kara Marker
The Nova Scotia Health Authority in Canada is leading a hepatitis C study at the Prince Edward Island's (PEI) provincial correctional center. Hepatitis C is an RNA virus that mutates quickly. It affects about 2.7 million people in the United States (CDC). Ongoing infection with hepatitis C majorly contributes to chronic liver disease. Hepatitis C can be cured, but there's no vaccine to prevent infection. Thus, people cannot prevent ever getting the viral infection in the first place OR protect themselves from contracting the virus a second time after being cured. 

The PEI study is utilizing the highly successful new direct-acting antiviral hepatitis C drugs (90-97% cure sucess) in a correctional facility that has a 23% infection rate of hepatitis C. The study's goals are twofold; scientists plan to reduce the prevalence of hepatitis C infections in the facility as well as see how the the new medication protects patients against reinfection. The new drugs have few side effects and can be taken orally, making them much better candidates for use in correctional facitlities than previous treatments, which were "given intravenously over long periods of time, with side effects including pain, fatigue and low blood counts" (Medical Xpress). 
A Time Course Progression of a Chronic Hepatitis C Infection

Ongoing research focused on providing a vaccine for hepatitis C continues and was discussed in an August journal article in Current Opinion in Immunology. Since hepatitis C largely contributes to chronic liver disease, the goal of hepatitis C vaccine research is specifically preventing recurring infections, rather than to "induce sterilizing immunity" (Current Opinion in Immunology). Decreasing the overall burden of chronic liver disease is a priority.

Current potential vaccines undergoing clinical trials include:
  1. non-structural hepatitis C viral proteins that induce CD8+ T cell immunity
  2. recombinant hepatitis C viral envelope proteins that are targeted by neutralizing antibodies
Curing and then preventing future hepatitis C infections with a vaccine will be especially important for individuals in high-risk populations, like in the Canadian correctional facility. Although the role of antibodies verus T cells in providing the most protective immunity is still intensely debated, ongoing research will soon tell if developing a vaccine for hepatitis C is possible. Even more, initiatives like the PEI study could help determine whether the new direct-acting antiviral agents make T cell immunity more or less possible in preventing against hepatitis C infections. 

Check out the video below to learn more about the pathology of a hepatitis C infection. 


Source: Medical Xpress
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 15, 2020
Immunology
Does COVID-19 Attack the Immune System like HIV?
APR 15, 2020
Does COVID-19 Attack the Immune System like HIV?
Researchers from the US and China have found that COVID-19 can destroy T cells, a type of lymphocyte that plays a key ro ...
MAY 13, 2020
Drug Discovery & Development
Fecal Transplant Helps Fight off Antibiotic Resistance
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
JUN 10, 2020
Immunology
Natural Killer Cells with "Memory" to Target Hepatitis B
JUN 10, 2020
Natural Killer Cells with "Memory" to Target Hepatitis B
An immune cell type thought to be restricted to the general, first response to pathogenic invaders may actually have som ...
JUN 23, 2020
Immunology
Nanosponges Mop up Viruses to Treat COVID Infections
JUN 23, 2020
Nanosponges Mop up Viruses to Treat COVID Infections
  Scientists have developed an experimental therapy for COVID-19 that uses coated nanoparticles to intercept SARS-C ...
JUL 07, 2020
Immunology
Existing drugs can prevent SARS-CoV-2 from hijacking cells
JUL 07, 2020
Existing drugs can prevent SARS-CoV-2 from hijacking cells
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins i ...
JUL 07, 2020
Coronavirus
No Evidence Showing Asthma Increases Severity of COVID-19
JUL 07, 2020
No Evidence Showing Asthma Increases Severity of COVID-19
Scientists have been scrambling to learn as much as possible about the novel coronavirus, which causes the disease COVID ...
Loading Comments...